Finance

Lists
002728:SHE
Teyi Pharmaceutical Group Co Ltd
9,65 CN¥
-0,72%
(-0,070) 1D
16-окт., 15:04:54 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002728...
Open
9,69 CN¥
High
10,20 CN¥
Low
9,60 CN¥
Mkt. cap
4,99 млд
Avg. vol.
19,12 млн
Volume
31,46 млн
Dividend
1,55%
Quarterly dividend
0,04 CN¥
Ex-dividend date
2026-ж., 18-июн.
P/E ratio
69,16
52-wk high
15,21 CN¥
52-wk low
7,66 CN¥
EPS
0,14 CN¥
Shares outstanding
513,31 млн
No. of employees
1 миң
Open
9,69 CN¥
High
10,20 CN¥
Low
9,60 CN¥
Mkt. cap
4,99 млд
Avg. vol.
19,12 млн
Volume
31,46 млн
Dividend
1,55%
Quarterly dividend
0,04 CN¥
Ex-dividend date
2026-ж., 18-июн.
P/E ratio
69,16
52-wk high
15,21 CN¥
52-wk low
7,66 CN¥
EPS
0,14 CN¥
Shares outstanding
513,31 млн
No. of employees
1 миң
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
13 мүнөт мурун
Cybin (NASDAQ:HELP) Upgraded at Wall Street Zen
Simply Wall Street
Simply Wall Street
·
51 мүнөт мурун
What AAON Bears Saw Before The Fall
Trefis
Trefis
·
52 мүнөт мурун
1 S&P 500 Stock Hit A 52-Week Low On Friday
About Teyi Pharmaceutical Group Co Ltd
CEO-
Employees1,43 миң
Founded2002-ж., 23-май
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
200,71 млн
232,68 млн
209,87 млн
183,45 млн
Cost of goods sold
102,58 млн
123,26 млн
81,88 млн
87,55 млн
Cost of revenue
102,58 млн
123,26 млн
81,88 млн
87,55 млн
Research and development expenses
11,06 млн
14,19 млн
9,25 млн
11,05 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62,18 млн
83,64 млн
85,27 млн
75,71 млн
Operating expense
73,02 млн
102,76 млн
93,09 млн
88,23 млн
Total operating expenses
175,60 млн
226,01 млн
174,97 млн
175,78 млн
Operating income
25,11 млн
6,67 млн
34,91 млн
7,67 млн
Other non operating income
-755,83 миң
604,89 миң
-33,22 миң
-206,21 миң
EBT including unusual items
26,78 млн
7,45 млн
35,14 млн
7,17 млн
EBT excluding unusual items
24,81 млн
7,29 млн
35,61 млн
7,09 млн
Income tax expense
-433,06 миң
-9,00 млн
9,37 млн
1,83 млн
Effective tax rate
-1,62%
-120,80%
26,67%
25,48%
Other operating expenses
193,29 миң
4,17 млн
-340,24 миң
1,34 млн
Net income
27,21 млн
16,45 млн
25,76 млн
5,34 млн
Net profit margin
13,56%
7,07%
12,28%
2,91%
Earnings per share
-
-
-
-
Interest and investment income
1,03 млн
601,98 миң
1,52 млн
859,16 миң
Interest expense
-579,01 миң
-579,51 миң
-775,84 миң
-1,24 млн
Net interest expenses
449,92 миң
22,46 миң
742,40 миң
-376,54 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
41,20 млн
24,12 млн
52,36 млн
26,35 млн
Gain or loss from assets sale
-83,37 миң
68,45 миң
-
-802,00
AI content may include mistakes. Learn more
Google колдонмолору